Andere Sprachen Bio Vitos Pharma AB

Aktien

A2DNT7

SE0009320278

BIOVIT

Markt geschlossen - Nasdaq Stockholm Andere Börsenplätze 12:24:26 07.06.2024			% 5 Tage	% 1. Jan.
0,132 ^SEK	+10,00 %		-0,75 %	-44,54 %

14.02.	Bio Vitos Pharma AB (publ) berichtet über die Ergebnisse für das Geschäftsjahr zum 31. Dezember 2023	CI
14.02.	Bio Vitos Pharma AB (publ) meldet Ergebnis für das vierte Quartal zum 31. Dezember 2023	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	14.02.
Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	14.02.
Bio Vitos Pharma Teams Up with KFUM Kalmar to Explore Benefits of Iron Succinate for Female Athletes	12.02.
KFUM Kalmar and Bio Vitos Pharma enter into an agreement regarding a research study on Succifer	12.02.
KFUM Kalmar and Bio Vitos Pharma Sign Collaboration Agreement to Conduct Research Study on Succifer	12.02.
The European Patent Office EPO grants patent that is important to Bio Vitos Pharma	20.12.
The European Patent Office EPO Grants Patent to Bio Vitos Pharma AB	20.12.
Hemcheck Sweden AB will Change its Ticker to BIOVIT from HEMC	06.12.
Hemcheck Sweden AB will Change its Name to Bio Vitos Pharma AB	06.12.
Hemcheck Sweden AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	16.11.
Hemcheck completes the transaction with Bio Vitos	20.10.23
Hemcheck Sweden AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	30.08.23
Hemcheck has received a first order from its distributor Astemed	15.05.23
Hemcheck Sweden AB Receives A First Order from Its Distributor Astemed	15.05.23
Hemcheck Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2023	09.05.23
Hemcheck submits a formal application to Nasdaq for a decision on continued listing before the implementation of the Bio Vitos agreement	04.05.23
Additional follow up order from the Foundation for Innovative New Diagnostics (FIND)	26.04.23
Hemcheck Sweden Receives New Follow Up Order from the Foundation for Innovative New Diagnostics	26.04.23
Hemcheck has received a first order from the university hospital Charité in Berlin	05.04.23
Hemcheck Sweden AB Receives First Order from the University Hospital Charité in Berlin	05.04.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bio Vitos Pharma AB

Aktien

A2DNT7

SE0009320278

BIOVIT

Andere Sprachen

Filter